Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas.
about
Evidence that SOX2 overexpression is oncogenic in the lungMolecular biology of lung cancer: clinical implicationsThe role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lungFGFR1 is an adverse outcome indicator for luminal A breast cancers.PPARĪ³ agonists regulate the expression of stemness and differentiation genes in brain tumour stem cellsThe SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysisSox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma.Prognostic significance of PIK3CA and SOX2 in Asian patients with lung squamous cell carcinoma.Sox2 activates cell proliferation and differentiation in the respiratory epithelium.Autologous anti-SOX2 antibody responses reflect intensity but not frequency of antigen expression in small cell lung cancer.Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer.The evolving role of the pathologist in the management of lung cancer.SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer.High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors.Detection of MET and SOX2 amplification by quantitative real-time PCR in non-small cell lung carcinoma.Increased Sox2 copy number in lung squamous cell carcinomas.The role of Sox genes in lung morphogenesis and cancer.SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer.Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer.Sox2 enhances the tumorigenicity and chemoresistance of cancer stem-like cells derived from gastric cancerExpression of seven stem-cell-associated markers in human airway biopsy specimens obtained via fiberoptic bronchoscopy.Targeting genomic alterations in squamous cell lung cancer.SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of OriginElevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer.Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis.Lung cancer stem cells: tools and targets to fight lung cancer.SOX1 antibodies in Lambert-Eaton myasthenic syndrome and screening for small cell lung carcinoma.Stem cells and cancer stem-like cells in endocrine tissues.Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice.Histo-cytological diagnostic accuracy in lung cancer.The dark side of SOX2: cancer - a comprehensive overview.The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer.Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer.SOX2 expression in the developing, adult, as well as, diseased prostateSOX2 and Rb1 in esophageal small-cell carcinoma: their possible involvement in pathogenesis.Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis.LSD1 demethylase and the methyl-binding protein PHF20L1 prevent SET7 methyltransferase-dependent proteolysis of the stem-cell protein Sox2.Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastases.SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer
P2860
Q21091126-9F69CB48-328F-4BDA-B072-EEB928BC242CQ24610335-B760BDE3-4C7E-4869-B989-A80350B12866Q26822879-BA46683A-2FF4-472D-9336-28AB54A53EB4Q27853294-DC35DFD2-84DD-4782-80C0-EEF801DE9649Q30454765-BCC7775B-46EC-443E-AFC7-76CBC92B385CQ33787478-82318C39-4C8F-44F5-A20B-17844406D0B2Q34073818-D06B2E66-C562-437E-AC7D-F81515D9DD0DQ34775815-70B4AE6D-C12D-4CA6-8690-798939605983Q35132159-04693D43-0CCF-497F-9831-F133FCBBFA39Q35190155-BA78D025-E6EA-4C60-B64C-790748A4BAFCQ35896945-A32E042F-5219-4330-B593-B057E8FBAA9DQ35951079-B2744EF5-E1E6-4881-AD8C-6BCC1E6C590DQ36076413-9A8158B0-7827-430A-94ED-A47F9E9B022AQ36085409-27957B96-9D89-4C39-A2AE-43D314A54A05Q36135757-E40F8C2F-9E28-46A1-B950-792453A1A365Q36225378-16E0C103-84D2-4B88-9531-2637AFEF824BQ36538306-2F518166-084C-466E-B33A-004B3CB9D5FAQ36548775-CF43AD02-1E5F-4CA2-AAB2-2626A25E43CAQ36568988-07EAFE69-64C0-4067-AF51-06832FEBD341Q36721378-F055837F-D11F-476F-9CA6-12243752CABEQ36732896-4504FEF2-A63F-4642-A89F-9B134D542449Q36946984-95EF837C-7565-482E-B071-5625D2885F23Q37068767-8E9DD134-3122-4C5F-9CD7-694C7354F70AQ37340964-3DDA3D3B-0A2D-483F-B536-C7BA428A240FQ37349481-97E886C5-9754-4AA5-B79C-3C68965D74E7Q37376323-9CA52C61-94F4-4F3B-AACD-113E594C08CEQ37763495-9BE6673E-45C1-4AFE-BE24-E7DAB588F340Q38070757-8633E162-4000-47BA-9CAE-3DBF6E0D5A80Q38084129-A8672FEA-48DD-497A-8FC6-104DB9CA43FAQ38112386-0F9697DA-6A70-4785-9FCB-281B62BD8FB9Q38164052-A2E84706-3EED-4D3F-B6BF-325A49EA4DBEQ38733504-A202895F-2C94-4199-8239-586F552AA68EQ39111034-BDCC404A-710D-4E63-96A1-7C1D6E8153E7Q39212619-EB0946AF-A46E-4328-9A08-C35304372B72Q42463444-54B48023-00A2-4EA0-AA36-C071D1EC832AQ42504523-8947A7AC-97D2-4F5E-8364-99BAE0CF5D87Q44280426-D77D0280-E01A-4B05-86CA-F349F71EDC40Q49874413-871DDFCF-C5D1-4083-99A6-5A774ABDB184Q54380228-1C1D33DC-32BF-4511-BAA0-FF2CED610166Q57693361-3D238C22-2E69-4CD7-BF2C-9D52C7DE8D93
P2860
Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas.
description
2010 nĆ® lÅ«n-bĆ»n
@nan
2010幓ć®č«ę
@ja
2010幓č«ę
@yue
2010幓č«ę
@zh-hant
2010幓č«ę
@zh-hk
2010幓č«ę
@zh-mo
2010幓č«ę
@zh-tw
2010幓č®ŗę
@wuu
2010幓č®ŗę
@zh
2010幓č®ŗę
@zh-cn
name
Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas.
@en
Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas.
@nl
type
label
Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas.
@en
Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas.
@nl
prefLabel
Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas.
@en
Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas.
@nl
P1476
Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas.
@en
P2093
Kevin B Long
Lynette M Sholl
P356
10.1097/PAI.0B013E3181B16B88
P577
2010-01-01T00:00:00Z